06/22/2026
Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of 2027.
But with less than two weeks before its launch, questions remain over how it will operate.
The Medicare GLP-1 Bridge, described by the Centers for Medicare and Medicaid Services (CMS) as a “time-limited demonstration,” will officially run from July 1, 2026, to Dec. 31, 2027.
Announced in December, the program will allow eligible Medicare Part D enrollees to access GLP-1 medications for a $50 monthly copay. Despite GLP-1s being indicated for diabetes, obesity and some heart conditions, the Bridge program will almost solely be available to beneficiaries seeking weight management solutions.
The program is meant for Medicare beneficiaries who do not have a medically coverable indication for GLP-1s through Part D coverage. Federal law currently prohibits Medicare from covering weight loss medications.
Credit: The Hill